What is Inference?
Inference Inc. is a specialized provider of comprehensive biometrics support services crucial for the drug development lifecycle. Their offerings encompass biostatistics, statistical programming, pharmacokinetics, data management, and medical writing. Operating as an independent statistical center, Inference Inc. delivers essential data monitoring and regulatory statistics, thereby safeguarding the integrity of clinical trials. The company partners with biotech and pharmaceutical firms, offering expert guidance to facilitate successful regulatory submissions and informed decision-making. Their commitment to high-quality, unbiased analyses positions them as a trusted ally in the healthcare and life sciences industries.
How much funding has Inference raised?
Inference has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for Inference?
With the recent influx of capital, Inference is poised for accelerated expansion and enhanced service delivery within the competitive biometrics support landscape. This large-scale, late-stage funding suggests a strategic focus on scaling operations, potentially through expanding service offerings, investing in advanced technological infrastructure, or broadening its client base. The company's trajectory indicates a strong emphasis on solidifying its market leadership and supporting an increasing volume of complex drug development projects, aiming for further regulatory milestones and market penetration.
See full Inference company page
